Thepharmaletter

Published October 6, 2026

Epicrispr reports muscle gains in early FSHD trial | Biotechnology | The Pharmaletter

Read the full story at Thepharmaletter

US biotech company Epicrispr Biotechnologies has reported ... What big pharma's entry signals for psychedelic medicine. 5 October 2026.